Carbon Modelling

PHASE

For Pharmaceutical leaders who have initiated Product Carbon reporting and Life Cycle Assessment, but recognise the increasing pressure to go further to secure Market Access and deliver Sustainability commitments… 

PHASE turns high volumes of static LCA data into an instant, dynamic decision-making tool. Tailored to an organisation’s priority areas of focus and capturing the impact of planned and in-flight carbon-reduction projects, PHASE transforms the pace of carbon decision-making.

Model, predict and optimise product carbon footprint

Without the need for LCA expertise and the resource required to manually model static product reporting data, PHASE accelerates carbon decision-making through:

• Instant identification of carbon hot-spots across supply chains
• Rapid scenario planning across manufacturing, formulation and supply chain choices
• Live visuals to explore “What if?” questions and project impact – available to any team or department
• Giving a clear, real-time view of where value is being created and impact is still to be unlocked

PHASE transforms the pace of carbon decision-making - tailored to the company's focus areas

• Designed for decision-making
• Uses existing LCA data
• Models intervention impact
• Available to any team
• Tailored to company focus areas
• Instant visualisation

How it works

PHASE centralises product carbon data so a company can see performance across sites and suppliers, test out changes, compare scenarios, and track progress against targets. It applies a consistent carbon methodology across portfolios so a company can make clear, confident decisions.

PHASE is configured around a company's portfolio, strategic priorities and operational reality, integrating both planned and in-flight carbon initiatives, giving a clear, real-time view of where value is being created and where impact is still to be unlocked.